KuangChi Science Limited (HK:0439)
:0439
Want to see HK:0439 full AI Analyst Report?
Top Page
KuangChi Science Limited
(0439)
Select Model
Select Model
Rating:43Neutral
Price Target:
HK$0.70
▼(-40.34% Downside)
Action:ReiteratedDate:04/30/26
The score is held down primarily by weak financial performance (revenue contraction, ongoing losses, and cash burn). Technicals also weigh on the outlook with a clear downtrend and negative momentum, while valuation is unfavorable due to loss-making earnings and no dividend support. A low-leverage balance sheet is the main stabilizing factor.
Positive Factors
Low leverage / strong balance sheet
Low measured leverage and improving debt metrics provide durable financial flexibility. With debt in the low single digits versus equity, the company can sustain operating volatility, access credit on better terms, and has more runway to execute restructuring or strategic initiatives without immediate solvency pressure.
Negative Factors
Contracting revenue trend
An ~18% revenue decline and prior volatility are structurally problematic: shrinking top line reduces absorption of fixed costs, undermines operating leverage, and signals potential erosion of market position or order flow. Sustained revenue contraction impairs recovery prospects even with a strong balance sheet.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
Low measured leverage and improving debt metrics provide durable financial flexibility. With debt in the low single digits versus equity, the company can sustain operating volatility, access credit on better terms, and has more runway to execute restructuring or strategic initiatives without immediate solvency pressure.
Read all positive factors
KuangChi Science Limited (0439) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$437.14M
Dividend YieldN/A
Average Volume (3M)911.76K
Price to Earnings (P/E)―
Beta (1Y)2.18
Revenue Growth-16.58%
EPS Growth-197.92%
CountryHK
Employees131
SectorIndustrials
Sector Strength72
IndustryAerospace & Defense
Share Statistics
EPS (TTM)-0.23
Shares Outstanding615,692,900
10 Day Avg. Volume686,570
30 Day Avg. Volume911,756
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.25
Price to Sales (P/S)10.85
P/FCF Ratio-6.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
KuangChi Science Limited Business Overview & Revenue Model
Company Description
Genesis Scale Holdings Ltd. operates as an investment holding company. The firm engages in the research and development, and manufacturing of innovative products for future technology business, and provision of other innovative technology service ...
KuangChi Science Limited Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
74
Positive
Cash Flow
22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 62.99M | 75.51M | 83.14M | 52.52M | 113.97M |
| Gross Profit | 16.38M | 20.74M | 14.68M | 10.83M | 41.73M |
| EBITDA | -26.43M | -74.79M | -4.51M | -61.82M | -29.28M |
| Net Income | -141.22M | -47.43M | -7.29M | -67.91M | -40.61M |
Balance Sheet | |||||
| Total Assets | 3.24B | 3.20B | 1.83B | 1.98B | 2.77B |
| Cash, Cash Equivalents and Short-Term Investments | 210.97M | 152.56M | 263.55M | 164.96M | 318.68M |
| Total Debt | 65.53M | 90.49M | 115.50M | 141.74M | 178.95M |
| Total Liabilities | 475.27M | 474.25M | 334.40M | 362.69M | 545.67M |
| Stockholders Equity | 2.76B | 2.73B | 1.49B | 1.62B | 2.22B |
Cash Flow | |||||
| Free Cash Flow | -110.30M | -94.51M | -52.68M | -92.82M | 82.82M |
| Operating Cash Flow | -107.84M | -80.87M | -43.59M | -77.91M | 105.22M |
| Investing Cash Flow | 138.41M | 162.66M | 43.10M | -104.25M | 369.21M |
| Financing Cash Flow | -29.59M | -21.65M | -22.38M | -23.79M | -325.97M |
KuangChi Science Limited Technical Analysis
Negative
1.18
Price Trends
0.94
Negative
1.06
Negative
1.25
Negative
Market Momentum
-0.05
Negative
35.23
Neutral
30.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0439, the sentiment is Negative. The current price of 1.18 is above the 20-day moving average (MA) of 0.79, above the 50-day MA of 0.94, and below the 200-day MA of 1.25, indicating a bearish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 35.23 is Neutral, neither overbought nor oversold. The STOCH value of 30.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0439.
KuangChi Science Limited Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$1.65B | 14.54 | 3.91% | 3.60% | 10.74% | 68.33% | |
70 Outperform | HK$660.00M | 1.48 | 10.92% | ― | 13.91% | 1.55% | |
65 Neutral | HK$792.06M | 3.29 | 7.36% | 4.69% | 3.73% | 17.95% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | HK$847.90M | -5.85 | -85.86% | ― | 39.72% | -764.89% | |
49 Neutral | HK$433.76M | -1.07 | -1308.62% | ― | 104.37% | -15.45% | |
43 Neutral | HK$437.14M | -4.84 | -5.37% | ― | -16.58% | -197.92% |
* Industrials Sector Average
HK:0439
KuangChi Science Limited
0.71
-0.45
-38.79%
HK:0232
Continental Aerospace Technologies Holding Ltd.
0.18
0.07
69.81%
HK:1463
C-Link Squared Limited
0.30
0.08
34.70%
HK:1725
Hong Kong Aerospace Technology Group Limited
0.54
-0.11
-16.92%
HK:1756
China Vocational Education Holdings Limited
0.53
-0.03
-5.36%
HK:2377
China Boqi Environmental (Holding) Co., Ltd.
0.97
0.28
40.58%
KuangChi Science Limited Corporate Events
Genesis Scale Grants 12.31 Million Share Options to Directors and Staff
Apr 30, 2026
Genesis Scale Holdings Limited has granted 12,310,000 share options, equivalent to about 2% of its issued share capital, to eight eligible participants under its share option scheme adopted in December 2025. The grantees include three executive di...
Genesis Scale Sets June 2026 AGM to Vote on Board, Auditor and Share Mandate
Apr 27, 2026
Genesis Scale Holdings Limited has called its annual general meeting for 30 June 2026 in Hong Kong, where shareholders will vote on receiving the audited financial statements for the year ended 31 December 2025 and reappointing Prism Kong Hong Lim...
Genesis Scale Sets Out Shareholder Preferences for 2025 Corporate Communications
Apr 27, 2026
Genesis Scale Holdings has notified its registered shareholders that the English and Chinese versions of its 2025 annual report, circular, notice of annual general meeting and proxy form are now available online on the company’s website and ...
Genesis Scale Wins Shareholder Approval to Sell Up to 40.8 Million KCT Shares
Apr 15, 2026
Genesis Scale Holdings Limited obtained shareholder approval at a special general meeting on 15 April 2026 for a mandate to dispose of up to 40,799,936 KuangChi Science (KCT) shares held by the group. The KCT Share Sales Mandate, valid for 12 mont...
Genesis Scale Announces Resignation of Two Non-Executive Directors
Apr 8, 2026
Genesis Scale Holdings Limited announced that non-executive directors Dr. Wong Kai Kit and Mr. Li Chiu Ho have resigned from the board, effective 8 April 2026, citing a desire to devote more time to personal commitments. Both departing directors c...
Genesis Scale Sets Out Board and Committee Structure
Apr 8, 2026
Genesis Scale Holdings Limited has announced the current composition of its board of directors, naming Dr. Zhang Yangyang as chairman, Dr. Liu Weiwen as chief executive officer, and Mr. Lin Ge as an executive director, alongside three independent ...
Genesis Scale Holdings to Modernise Bye-Laws for Paperless Reforms and Treasury Shares
Mar 30, 2026
Genesis Scale Holdings Limited plans to update its corporate Bye-Laws to align with Hong Kong Stock Exchange listing rule changes, especially those stemming from the January 2025 paperless listing reforms. The move will modernise shareholder engag...
Genesis Scale Warns on Potential Forced Sale of Nearly 10% Stake
Mar 27, 2026
Genesis Scale Holdings Limited, incorporated in Bermuda and listed in Hong Kong under stock code 439, operates through a group structure with executive, non-executive and independent non-executive directors overseeing its governance. The company&#...
Genesis Scale Seeks Shareholder Mandate to Sell KuangChi Science Stake
Mar 26, 2026
Genesis Scale Holdings Limited has called a special general meeting in Hong Kong on 15 April 2026 to seek shareholder approval for a mandate to dispose of up to 40,799,936 KuangChi Science shares held by the group. The proposed mandate, valid for ...
Genesis Scale Sets April SGM and Book Closure for Potential Major Disposal
Mar 23, 2026
Genesis Scale Holdings Limited has scheduled a special general meeting (SGM) for 15 April 2026 in Hong Kong to seek shareholder approval for a possible very substantial disposal involving KCT share sales under an existing mandate. The company will...
Genesis Scale Sets March 2026 Board Meeting to Approve 2025 Results and Consider Dividend
Mar 13, 2026
Genesis Scale Holdings Limited has scheduled a board meeting for 30 March 2026 to review and approve the audited final results of the company and its subsidiaries for the financial year ended 31 December 2025. The board will also consider whether ...
Genesis Scale Delays Circular on Planned Major Disposal
Mar 6, 2026
Genesis Scale Holdings Limited announced a delay in sending a shareholder circular related to a proposed very substantial disposal involving potential sales of shares in KCT under an existing share sales mandate. The circular, which was originally...
Genesis Scale Warns of Sharply Wider 2025 Net Loss on Legal Provision
Feb 16, 2026
Genesis Scale Holdings Limited has warned shareholders that it expects to report a significantly larger net loss for the year ended 31 December 2025, projecting a deficit of between HK$130 million and HK$150 million versus a HK$47.4 million loss a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.